Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
S
Sylvie van der Werf
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
479
Papers
31.3K
Citations
76
h-index
256
i10-index
Sylvie van der Werf is an academic researcher. The author has contributed to research in topics: Influenza Virus Research Studies & SARS-CoV-2 and COVID-19 Research & Respiratory viral infections research. The author has an h-index of 76, co-authored 408 publications.
ORCID: 0000-0002-1148-4456Papers by this author
worksAutoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Primary structure, gene organization and polypeptide expression of poliovirus RNA
1981 · Nature · 905 citations
https://doi.org/10.1038/291547a0
Syncytia formation by SARS‐CoV‐2‐infected cells
2020 · The EMBO Journal · 494 citations
https://doi.org/10.15252/embj.2020106267
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat